Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)

NCT04705844 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study withdrawn prior to screening subjects

Conditions

Mild to Moderate COVID-19

Interventions

DRUG: Adalimumab
DRUG: Placebo

Sponsor

Alachua Government Services, Inc.

Collaborators

[object Object]
[object Object]